KOSDAQ large cap
AprilBio
A biotech developing autoimmune and inflammatory therapies based on its SAFA antibody half-life-extension platform. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
397030.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'23+57%'24+25.1%'25+259%YTD-53.2%
Money in ▸·
AprilBio
▸ Money out·
Financials & Segments
- Segments · Antibody drug R&D · Licensing (SAFA platform)
Revenue from
No refined links yet.
Pays to
No refined links yet.